Stock screenerAll disclosures →
EDGAR →
ASMB
Conviction 28HealthcareScan · Thu, Jun 25, 2026ASMB$24.26-5.31%
ResistanceSupportVol 14Insider sellVol MA14 232.17K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price24.26
Change-5.31%
Gap-0.23%
Rel volume2.84×
Avg volume219.83K
Avg $ vol5.37M
SMA 2024.42
SMA 5026.88
SMA 20028.92
Price vs 50-9.75%
Price vs 200-16.11%
MA stackbearish
50/200 cross—
Supertrenddown · 27.00
RSI (14)45
MACD hist0.36
MACD crossbull · 4d
Stoch %K / %D40 / 65
ADX (14)16
+DI / −DI28 / 20
RSI divergence—
MACD divergence—
ATR %+6.93%
ADR %6.36%
52w high38.50
52w low17.08
From 52w high-36.99%
Above 52w low+42.04%
New 52w highNo
SqueezeOff
Bollinger width27.64%
%B0.48
Donchian pos35.44%
Donchian high28.75
Donchian low21.80
AVWAP (52w high)29.06
vs AVWAP high-16.51%
AVWAP (52w low)27.95
vs AVWAP low-13.20%
OBV trendFlat
Chaikin MF (20)-0.27
Today vs 20d2.84×
Avg vol (14d)232.17K
Avg vol (20d)219.83K
Avg $ vol (20d)5.37M
Market cap385.55M
RS 3m (vs SPY)-21.50%
RS 6m (vs SPY)-35.08%
RS line new highNo
Trend template2/8
Technical rank18.0
1 week+0.46%
1 month-15.62%
3 months-15.38%
6 months-32.95%
1 year+41.05%
YTD-28.11%
P/E-62.98
P/B1.94
P/S5.33
P/FCF-9.37
EPS-0.5500
Div yield—
ROE-3.08%
ROA-2.60%
Debt/Eq0.00
Current6.65
EV/EBITDA-29.60
Gross margin—
Net margin-8.47%
Rev growth153.52%
EPS growth84.76%
Price target46.00
Target upside89.61%
Analyst ratingBuy
Institutional72.38%
Ent. value354.85M
Revenue—
Net income-9.08M
Gross profit—
Free cash flow-41.16M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees73
ListedFri, Dec 17, 2010
Free float10.87M
Float %68.4%
Short interest1.68M
Days to cover7.5d
Short volume25.2%
Squeeze score71 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.70 · 1 est
Last EPS vs est−$0.54 vs −$0.73
Last surprise+26.0% beat
Setup gradeD
Conviction28 / 100
Pattern quality—
Tech rank18.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance32.18
Support23.78
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ASMB
No recent disclosed trades by Congress in ASMB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ASMB · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bjorkquist Jeanette M PFO and PAO · Common Stock · 2026-06-17 | Sell | 29 | $674 | 2026-06-17 | 2026-06-18 |
Houghton Michael Director · Stock Option (right to buy) · 2026-06-04 | Grant | 8K | $0 | 2026-06-04 | 2026-06-05 |
Mahony Susan Director · Stock Option (right to buy) · 2026-06-04 | Grant | 8K | $0 | 2026-06-04 | 2026-06-05 |
Consylman Gina Director · Stock Option (right to buy) · 2026-06-04 | Grant | 8K | $0 | 2026-06-04 | 2026-06-05 |
Johnson-Pratt Lisa Director · Stock Option (right to buy) · 2026-06-04 | Grant | 8K | $0 | 2026-06-04 | 2026-06-05 |
McHutchison John G Director · Stock Option (right to buy) · 2026-06-04 | Grant | 8K | $0 | 2026-06-04 | 2026-06-05 |
ALTIG ANTHONY E Director · Stock Option (right to buy) · 2026-06-04 | Grant | 8K | $0 | 2026-06-04 | 2026-06-05 |
Delaney William E IV Chief Scientific Officer · Common Stock · 2026-03-29 | Grant | 14K | $0 | 2026-03-29 | 2026-06-05 |
Gaggar Anuj Chief Medical Officer · Common Stock · 2026-03-29 | Grant | 14K | $0 | 2026-03-29 | 2026-06-05 |
White Nicole S Chief Manufacturing Officer · Common Stock · 2026-03-29 | Grant | 14K | $0 | 2026-03-29 | 2026-06-05 |
SEC filings
EDGAR filings in ASMB · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.